Literature DB >> 10971505

Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.

D A Lammas1, J L Casanova, D S Kumararatne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971505      PMCID: PMC1905729          DOI: 10.1046/j.1365-2249.2000.01284.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  31 in total

1.  Interferon-gamma receptor deficiency: An expanding clinical phenotype?

Authors:  J L Casanova; H Ochs
Journal:  J Pediatr       Date:  1999-11       Impact factor: 4.406

2.  Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.

Authors:  F Novelli; P Bernabei; L Ozmen; L Rigamonti; A Allione; S Pestka; G Garotta; G Forni
Journal:  J Immunol       Date:  1996-09-01       Impact factor: 5.422

3.  Immunological conditions of children with BCG disseminated infection.

Authors:  J L Casanova; E Jouanguy; S Lamhamedi; S Blanche; A Fischer
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

4.  In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.

Authors:  E Jouanguy; S Dupuis; A Pallier; R Döffinger; M C Fondanèche; C Fieschi; S Lamhamedi-Cherradi; F Altare; J F Emile; P Lutz; P Bordigoni; H Cokugras; N Akcakaya; J Landman-Parker; J Donnadieu; Y Camcioglu; J L Casanova
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 5.  Listeria monocytogenes and recurrent mycobacterial infections in a child with complete interferon-gamma-receptor (IFNgammaR1) deficiency: mutational analysis and evaluation of therapeutic options.

Authors:  J Roesler; B Kofink; J Wendisch; S Heyden; D Paul; W Friedrich; J L Casanova; W Leupold; M Gahr; A Rösen-Wolff
Journal:  Exp Hematol       Date:  1999-09       Impact factor: 3.084

6.  Partial interferon-gamma receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection.

Authors:  R Döffinger; E Jouanguy; S Dupuis; M C Fondanèche; J L Stephan; J F Emile; S Lamhamedi-Cherradi; F Altare; A Pallier; G Barcenas-Morales; E Meinl; C Krause; S Pestka; R D Schreiber; F Novelli; J L Casanova
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits.

Authors:  D H Presky; H Yang; L J Minetti; A O Chua; N Nabavi; C Y Wu; M K Gately; U Gubler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation.

Authors:  D M Frucht; S M Holland
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

9.  Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene?

Authors:  M Levin; M J Newport; S D'Souza; P Kalabalikis; I N Brown; H M Lenicker; P V Agius; E G Davies; A Thrasher; N Klein
Journal:  Lancet       Date:  1995-01-14       Impact factor: 79.321

10.  Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma. A preliminary report.

Authors:  S M Holland; E M Eisenstein; D B Kuhns; M L Turner; T A Fleisher; W Strober; J I Gallin
Journal:  N Engl J Med       Date:  1994-05-12       Impact factor: 91.245

View more
  24 in total

1.  Disseminated Mycobacterium tuberculosis infection due to interferon gamma deficiency. Response to replacement therapy.

Authors:  Suranjith Luke Seneviratne; Rainer Doffinger; John Macfarlane; L Ceron-Gutierrez; M R Amel Kashipaz; A Robbins; T Patel; P T Powell; D S Kumararatne; Richard J Powell
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  Extensively drug resistant tuberculosis in a 7-year-old child with interferon-γ and interleukin-12 deficiency.

Authors:  Ketan Kulkarni; Meenu Singh; Pooja Soneja; Joseph Mathew; Ram Kumar Marwaha
Journal:  BMJ Case Rep       Date:  2009-02-16

Review 3.  The current state of tuberculosis vaccines.

Authors:  David A Hokey; Ann Ginsberg
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

4.  IL-2 and IL-18 attenuation of airway hyperresponsiveness requires STAT4, IFN-gamma, and natural killer cells.

Authors:  Shigeki Matsubara; Katsuyuki Takeda; Taku Kodama; Anthony Joetham; Nobuaki Miyahara; Toshiyuki Koya; Christina H Swasey; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Cell Mol Biol       Date:  2006-10-12       Impact factor: 6.914

Review 5.  The hygiene theory harnessing helminths and their ova to treat autoimmunity.

Authors:  Dana Ben-Ami Shor; Michal Harel; Rami Eliakim; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 6.  Infections in patients with inherited defects in phagocytic function.

Authors:  Timothy Andrews; Kathleen E Sullivan
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

7.  The changing microbial environment and chronic inflammatory disorders.

Authors:  Graham Aw Rook
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

Review 8.  Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders.

Authors:  G A W Rook; V Adams; J Hunt; R Palmer; R Martinelli; L Rosa Brunet
Journal:  Springer Semin Immunopathol       Date:  2003-10-08

Review 9.  [Classification and diagnosis of immunodeficiency syndromes].

Authors:  K Warnatz; H-H Peter
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

Review 10.  Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway.

Authors:  David A Lammas; E De Heer; J D Edgar; V Novelli; A Ben-Smith; R Baretto; P Drysdale; J Binch; C MacLennan; D S Kumararatne; S Panchalingam; T H M Ottenhoff; J-L Casanova; J F Emile
Journal:  Int J Exp Pathol       Date:  2002-02       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.